InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by LAWLIS V BRYAN, Director. Officer active across 1 companies, notably Biomarin Pharmaceutical INC. In total, 6 filings have been logged. The latest transaction was filed on 24 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
04,980 shares0
Common Stock
SEC:0001567619-22-011796:0·
€147,1264,250 shares@ €34.61790.0013% mcap34.6% of flow
Common Stock
SEC:0001567619-22-008633:0·
€138,9574,250 shares@ €32.6958100.0% of flow
Common Stock
SEC:0001567619-22-001334·
€138,9574,250 shares@ €32.69580.0012% mcap32.7% of flow
Common Stock
SEC:0001567619-22-001334:0·
05,120 shares0
Common Stock
SEC:0001567619-21-011314·
05,120 shares0
Common Stock
SEC:0001567619-21-011314:0·
6 of 6 declarations
About LAWLIS V BRYAN
Bryan V. Lawlis is a Director at BIOMARIN PHARMACEUTICAL INC. As a board member, he provides his expertise to guide the company's strategy and ensure good governance. His experience is valuable for BIOMARIN.
